Prevention of cytomegalovirus following solid organ transplantation: A literature review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention of cytomegalovirus following solid organ transplantation: A literature review
Authors
Keywords
-
Journal
PEDIATRIC TRANSPLANTATION
Volume 17, Issue 6, Pages 499-509
Publisher
Wiley
Online
2013-07-29
DOI
10.1111/petr.12118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
- (2012) D. J. Winston et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
- (2012) O. Manuel et al. CLINICAL INFECTIOUS DISEASES
- State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
- (2012) A. Egli et al. CLINICAL INFECTIOUS DISEASES
- Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection
- (2012) Davide Abate et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: A systematic review and meta-analysis
- (2012) Andre C. Kalil et al. LIVER TRANSPLANTATION
- Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients
- (2012) Marta Bodro et al. LIVER TRANSPLANTATION
- Viral Infection in Renal Transplant Recipients
- (2012) Jovana Cukuranovic et al. TheScientificWorldJOURNAL
- Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients
- (2012) Björn Nashan et al. TRANSPLANTATION
- The next generation recombinant human cytomegalovirus vaccine candidates—Beyond gB
- (2012) Anders E. Lilja et al. VACCINE
- Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment
- (2012) Elena Beam et al. Current Infectious Disease Reports
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
- (2011) T. Goldner et al. JOURNAL OF VIROLOGY
- Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir
- (2011) Ashley N. Bedel et al. LIVER TRANSPLANTATION
- Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials
- (2011) L.-F. Zhang et al. Transplant Infectious Disease
- Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
- (2011) Luiz F. Lisboa et al. TRANSPLANTATION
- Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
- (2011) Oliver Witzke et al. TRANSPLANTATION
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effectiveness of Valganciclovir 900 mg versus 450 mg for Cytomegalovirus Prophylaxis in Transplantation: Direct and Indirect Treatment Comparison Meta-analysis
- (2010) A. C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections
- (2010) L K Dropulic et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
- (2010) Albert J. Eid et al. DRUGS
- The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation
- (2010) E. Lapidus-Krol et al. PEDIATRIC TRANSPLANTATION
- Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation
- (2010) Judith M. Martin et al. PEDIATRIC TRANSPLANTATION
- Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids
- (2010) Denis Glotz et al. TRANSPLANTATION
- International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
- (2010) Camille N. Kotton et al. TRANSPLANTATION
- 24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
- (2010) Andres F. Camacho-Gonzalez et al. TRANSPLANTATION
- Quantiferon-CMV Test in Prediction of Cytomegalovirus Infection After Kidney Transplantation
- (2010) A. Lochmanova et al. TRANSPLANTATION PROCEEDINGS
- Cytomegalovirus in Solid Organ Transplant Recipients
- (2009) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
- (2009) D. Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R−) solid organ transplant recipients
- (2009) R. San Juan et al. CLINICAL TRANSPLANTATION
- Delayed onset CMV disease in solid organ transplant recipients
- (2009) Shahid Husain et al. TRANSPLANT IMMUNOLOGY
- A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients
- (2009) Rebecca P. Madan et al. TRANSPLANTATION
- Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation
- (2008) Rafael San Juan et al. CLINICAL INFECTIOUS DISEASES
- Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts
- (2008) Nina Singh et al. LIVER TRANSPLANTATION
- Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients
- (2008) R.L. Brady et al. Transplant Infectious Disease
- Cytomegalovirus infection after liver transplantation: Current concepts and challenges
- (2008) Raymund-Rabe Razonable WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started